← NEWS
✦ Health · TrueWire

Knh’S New Machine Big Boost For Cancer Patients

img_tag = ("") if image_text else ""

Cancer patients across Kenya can finally breathe easier as Kenyatta National Hospital unveils cutting-edge radiotherapy equipment that promises to slash waiting times and save thousands of lives.

The country's largest referral hospital has commissioned a state-of-the-art linear accelerator machine that will dramatically expand cancer treatment capacity. Located at KNH's oncology department, the new equipment joins existing radiotherapy infrastructure to serve patients who previously faced months-long queues for life-saving treatment.

For years, Kenyan cancer patients have endured a heartbreaking reality – getting diagnosed but waiting up to six months for treatment while their condition worsens. Many families have been forced to sell everything, from their small businesses to their ancestral land, just to afford private treatment or travel abroad. Others have watched helplessly as their loved ones succumbed while stuck on endless waiting lists.

The timing couldn't be more critical. Cancer cases in Kenya have been rising steadily, with breast, cervical, and prostate cancers leading the statistics. Most patients come from rural counties where early detection remains a challenge, meaning they arrive at KNH when treatment is most urgent. The new machine means more patients can access treatment closer to home instead of the expensive journey to private facilities or overseas hospitals.

This development particularly impacts ordinary Kenyans who rely on public healthcare. A typical cancer patient from places like Kisumu or Meru would previously spend months in Nairobi, draining family resources on accommodation and transport while waiting for treatment. Now, the expanded capacity means faster access to care and less financial strain on families already struggling with medical bills.

The machine represents more than just new equipment – it's a lifeline for the estimated 40,000 Kenyans diagnosed with cancer annually. With NHIF coverage for cancer treatment still limited and private radiotherapy costing hundreds of thousands of shillings, public facilities like KNH remain the only hope for most patients.

Will this new capacity finally give ordinary Kenyans fighting cancer the same fighting chance that wealth has always provided, or do we need even more investment in public cancer care?